Clinical Trial Update: Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase I study of perifosine in combination with lenalidomide and dexamethasone in multiple myeloma has completed, with safety and early efficacy data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED